(VIANEWS) – New Fortress Energy (NFE), AMETEK (AME), RadNet (RDNT) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. New Fortress Energy (NFE)
35.2% sales growth and 34.1% return on equity
New Fortress Energy Inc. operates as an integrated gas-to-power energy infrastructure company that provides energy and development services to end-users worldwide. The company operates in two segments, Terminals and Infrastructure, and Ships. The Terminals and Infrastructure segment engages in the natural gas procurement and liquefaction; and shipping, logistics, facilities and conversion, or development of natural gas-fired power generation. The Ships segment offers floating storage and regasification units (FRSU) and liquefied natural gas (LNG) carriers which are leased to customers under long-term or spot arrangements. The company operates LNG storage and regasification facility at the Port of Montego Bay, Jamaica; marine LNG storage and regasification facility in Old Harbour, Jamaica; Dual-fired combined heat and power facility in Clarendon, Jamaica; landed micro-fuel handling facility in San Juan, Puerto Rico; and LNG receiving facility and gas-fired power plant in Baja Califrnia Sur, Mexico, as well as a Miami facility. New Fortress Energy Inc. was founded in 1998 and is based in New York, New York.
Earnings Per Share
As for profitability, New Fortress Energy has a trailing twelve months EPS of $2.65.
PE Ratio
New Fortress Energy has a trailing twelve months price to earnings ratio of 10.1. Meaning, the purchaser of the share is investing $10.1 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 34.1%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 38.8%, now sitting on 2.41B for the twelve trailing months.
Volume
Today's last reported volume for New Fortress Energy is 358400 which is 74.54% below its average volume of 1408060.
2. AMETEK (AME)
12.9% sales growth and 15.77% return on equity
AMETEK, Inc. manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry. Its EMG segment offers engineered medical components and devices, automation solutions, thermal management systems, specialty metals, and electrical interconnects; single-use and consumable surgical instruments, implantable components, and drug delivery systems; engineered electrical connectors and electronics packaging to protect sensitive devices and mission-critical electronics; precision motion control products for data storage, medical devices, business equipment, and automation; high-purity powdered metals, strips and foils, specialty clad metals, and metal matrix composites; motor-blower systems and heat exchangers for thermal management, military and commercial aircraft, and military ground vehicles; motors for commercial appliances, food and beverage machines, hydraulic pumps, and industrial blowers; and operates a network of aviation maintenance, repair, and overhaul facilities. AMETEK, Inc. was incorporated in 1930 and is headquartered in Berwyn, Pennsylvania.
Earnings Per Share
As for profitability, AMETEK has a trailing twelve months EPS of $5.67.
PE Ratio
AMETEK has a trailing twelve months price to earnings ratio of 31.69. Meaning, the purchaser of the share is investing $31.69 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.77%.
3. RadNet (RDNT)
8.6% sales growth and 6.37% return on equity
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.
Earnings Per Share
As for profitability, RadNet has a trailing twelve months EPS of $0.37.
PE Ratio
RadNet has a trailing twelve months price to earnings ratio of 155.27. Meaning, the purchaser of the share is investing $155.27 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.37%.
4. HCA Holdings (HCA)
6% sales growth and 845.54% return on equity
HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Earnings Per Share
As for profitability, HCA Holdings has a trailing twelve months EPS of $18.98.
PE Ratio
HCA Holdings has a trailing twelve months price to earnings ratio of 17.01. Meaning, the purchaser of the share is investing $17.01 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 845.54%.
Yearly Top and Bottom Value
HCA Holdings's stock is valued at $322.82 at 11:22 EST, under its 52-week high of $335.83 and way higher than its 52-week low of $215.96.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.2%, now sitting on 66.72B for the twelve trailing months.
Growth Estimates Quarters
The company's growth estimates for the ongoing quarter and the next is 12.8% and 15.3%, respectively.
Sales Growth
HCA Holdings's sales growth for the next quarter is 6%.
（VIANEWS）——新堡壘能源（NFE）、AMETEK（AME）、RadNet（RDNT）是該清單上銷售增長和股票回報率最高的股票。
以下是預計下一季度銷售增長超過5％，股本回報率爲3％或更高的股票清單。這些股票可能是一個不錯的中期投資選擇嗎？
1.新堡壘能源 (NFE)
35.2% 的銷售增長和 34.1% 的股本回報率
New Fortress Energy Inc. 是一家綜合的天然氣發電能源基礎設施公司，爲全球終端用戶提供能源和開發服務。該公司在兩個部門開展業務，即碼頭和基礎設施以及船舶。碼頭和基礎設施部門從事天然氣採購和液化；以及運輸、物流、設施和改造，或天然氣發電的開發。船舶部門提供浮動儲存和再氣化裝置（FRSU）和液化天然氣（LNG）運輸船，這些船是根據長期或現貨安排租賃給客戶的。該公司在牙買加蒙特哥灣港運營液化天然氣儲存和再氣化設施；牙買加老港的船用液化天然氣儲存和再氣化設施；牙買加克拉倫登的雙燃熱電聯產設施；波多黎各聖胡安的陸地微燃料處理設施；墨西哥南下加利福尼亞州的液化天然氣接收設施和燃氣發電廠以及邁阿密工廠。新豐澤能源公司成立於1998年，總部位於紐約州紐約。
每股收益
至於盈利能力，新堡壘能源的每股收益爲2.65美元。
市盈率
新豐澤能源過去十二個月的市盈率爲10.1。這意味着，該股票的購買者每1美元的年收益將投資10.1美元。
該公司的股本回報率爲34.1％，用於衡量企業相對於股東權益的盈利能力。
收入增長
季度收入同比增長38.8％，在過去的十二個月中目前爲24.1億美元。
成交量
新堡壘能源今天上次公佈的交易量爲358400輛，比其平均交易量1408060低74.54％。
2.AMETEK（AME）
12.9% 的銷售增長和 15.77% 的股本回報率
AMETEK, Inc. 在北美、歐洲、亞洲和南美以及國際上製造和銷售電子儀器和機電設備。該公司的EIG部門爲工藝、航空航天、電力和工業市場提供先進的儀器；爲石油和天然氣、石化、製藥、半導體、自動化以及食品和飲料行業提供過程和分析儀器；爲實驗室設備、超精密製造、醫療以及測試和測量市場提供儀器；電能質量監測和c設備、不間斷電源、可編程電源和電磁兼容性測試設備以及用於燃氣輪機和儀表板的傳感器儀器；用於食品和飲料行業的重型卡車、儀表和控制器；以及航空航天和國防工業的飛機和發動機傳感器、電源、嵌入式計算、監控、燃料和流體測量以及數據採集系統。其 EMG 部門提供工程醫療部件和設備、自動化解決方案、熱管理系統、特種金屬和電氣互連；一次性及消耗性手術器械、植入式組件和藥物輸送系統；用於保護敏感設備和任務關鍵電子產品的工程電氣連接器和電子包裝；用於數據存儲、醫療設備、商業設備和自動化的精密運動控制產品；高純度粉末金屬、條帶和箔片、特種複合金屬和金屬基質複合材料；用於熱管理、軍用和商用飛機、軍用地面車輛的電機鼓風機系統和熱交換器；用於商用電器、食品和飲料機器、液壓泵和工業鼓風機的電機；以及運營航空維護、維修和大修設施網絡。AMETEK, Inc. 成立於1930年，總部位於賓夕法尼亞州的伯溫。
每股收益
至於盈利能力，AMETEK的每股收益爲5.67美元。
市盈率
阿美特克過去十二個月的市盈率爲31.69。這意味着，該股票的購買者每1美元的年收益將投資31.69美元。
該公司的股本回報率爲15.77％，用於衡量企業相對於股東權益的盈利能力。
3.RadNet (RDNT)
8.6% 的銷售增長和 6.37% 的股本回報率
RadNet, Inc. 及其子公司在美國提供門診診斷成像服務。其服務包括磁共振成像、計算機斷層掃描、正電子發射斷層掃描、核醫學、乳房X光檢查、超聲波、診斷放射學、透視和其他相關程序，以及多模態成像服務。該公司還爲診斷成像行業開發和銷售計算機化系統，包括圖片存檔通信系統和相關服務；並開發和部署人工智能套件，以增強放射科醫生對乳腺造影領域圖像的解釋，以及肺癌和前列腺癌的人工智能解決方案。截至2021年12月31日，它在亞利桑那州、加利福尼亞州、特拉華州、佛羅里達州、馬里蘭州、新澤西州和紐約州擁有並管理347箇中心。該公司成立於1981年，總部位於加利福尼亞州洛杉磯。
每股收益
至於盈利能力，RadNet的每股收益爲0.37美元。
市盈率
RadNet過去十二個月的市盈率爲155.27。這意味着，該股票的購買者每1美元的年收益將投資155.27美元。
該公司的股本回報率爲6.37％，用於衡量企業相對於股東權益的盈利能力。
4.HCA 控股公司 (HCA)
6% 的銷售增長和 845.54% 的股本回報率
HCA Healthcare, Inc. 通過其子公司在美國擁有並經營醫院和相關醫療保健實體。它經營普通和急診醫院，提供醫療和外科服務，包括住院護理、重症監護、心臟護理、診斷和急診服務；以及門診服務，例如門診手術、實驗室、放射學、呼吸治療、心臟病學和物理治療。該公司還運營門診醫療保健設施，包括獨立的門診手術中心、獨立的緊急護理設施、緊急護理設施、步入式診所、診斷和成像中心、康復和物理治療中心、放射和腫瘤治療中心、醫生診所以及其他各種設施。此外，它還經營行爲醫院，提供治療計劃，包括兒童、青少年和成人精神病護理、青少年和成人酒精、藥物濫用治療和諮詢服務。該公司前身爲HCA控股有限公司。HCA Healthcare, Inc.成立於1968年，總部位於田納西州納什維爾。
每股收益
至於盈利能力，HCA Holdings的每股收益爲18.98美元。
市盈率
HCA Holdings過去十二個月的市盈率爲17.01。這意味着，該股票的購買者每1美元的年收益將投資17.01美元。
該公司的股本回報率爲845.54％，用於衡量企業相對於股東權益的盈利能力。
年度最高值和最低值
美國東部標準時間11點22分，HCA Holdings的股票估值爲322.82美元，低於其52周高點335.83美元，遠高於其52周低點215.96美元。
收入增長
季度收入同比增長11.2％，在過去的十二個月中目前爲667.2億美元。
增長估算季度
該公司對本季度和下一季度的增長預期分別爲12.8％和15.3％。
銷售增長
HCA Holdings下一季度的銷售增長爲6％。
